Medicare will now be providing reimbursement to hospitals for the use of 24 new treatment technologies, under a provision in the final rule for the Medicare acute and long-term care hospital prospective payment systems (PPS) for fiscal year (FY) 2021. The hospital PPS final rule, effective October 1, 2020, authorized new technology add-on payments (NTAP) for 13 new technologies, and continued NTAP for 10 technologies approved for FY 2020. The final rule also included conditional approval for one new technology for FY 2021. CMS estimates that FY 2021 Medicare spending on NTAPs will be approximately $874 million, nearly . . .